Cabozantinib for progressive metastatic medullary thyroid cancer: a review

Richard Wein, Joshua Colombo
  • Therapeutics and Clinical Risk Management, May 2014, Taylor & Francis
  • DOI: 10.2147/tcrm.s46041

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2147/tcrm.s46041

The following have contributed to this page: Dr Richard O Wein